Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.3 | 3e-18 |
mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.29 | 1e-15 |
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.26 | 2e-15 |
mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-15 |
mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.25 | 3e-14 |
mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.27 | 2e-13 |
mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-13 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-13 |
mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-12 |
mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.23 | 2e-12 |